Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

  • QYR679196
  • 100 Pages
  • September 2016
  • Pharmaceuticals
Download Sample    Get Discount   
 
Notes:

Sales, means the sales volume of Drugs for Respiratory Syncytial Virus (RSV)

Revenue, means the sales value of Drugs for Respiratory Syncytial Virus (RSV)

This report studies sales (consumption) of Drugs for Respiratory Syncytial Virus (RSV) in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

Ablynx

ADMA Biologics

Agilvax

AlphaVax

AmVac

Aridis Pharmaceuticals

Artificial Cell Technologies

Astellas Pharma

AstraZeneca

Bavarian Nordic

Biota Pharmaceuticals

Celltrion

Codagenix

Crucell

CureVac

Emergent

Roche

GenVec

Gilead Sciences

GlaxoSmithKline

Humabs BioMed

Novavax

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

Ribavirin

Bronchodilator

Type III

Split by applications, this report focuses on sales, market share and growth rate of Drugs for Respiratory Syncytial Virus (RSV) in each application, can be divided into

Infants (Under 6 Month Old)

Babies & Children

Adults

Table of Contents

United States Drugs for Respiratory Syncytial Virus (RSV) Market Report 2021

1 Drugs for Respiratory Syncytial Virus (RSV) Overview

1.1 Product Overview and Scope of Drugs for Respiratory Syncytial Virus (RSV)

1.2 Classification of Drugs for Respiratory Syncytial Virus (RSV)

1.2.1 Ribavirin

1.2.2 Bronchodilator

1.2.3 Type III

1.3 Applications of Drugs for Respiratory Syncytial Virus (RSV)

1.3.1 Infants (Under 6 Month Old)

1.3.2 Babies & Children

1.3.3 Adults

1.4 USA Market Size (Value and Volume) of Drugs for Respiratory Syncytial Virus (RSV) (2011-2021)

1.4.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)

1.4.2 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)

1.4.3 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)

2 USA Drugs for Respiratory Syncytial Virus (RSV) Competition by Manufacturers

2.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Share by Manufactures (2015 and 2016)

3 USA Drugs for Respiratory Syncytial Virus (RSV) (Volume and Value) by Type

3.1 USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)

3.2 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)

4 USA Drugs for Respiratory Syncytial Virus (RSV) (Volume) by Application

5 USA Drugs for Respiratory Syncytial Virus (RSV) Manufacturers Analysis

5.1 Ablynx

5.1.1 Company Basic Information, Manufacturing Base and Competitors

5.1.2 Drugs for Respiratory Syncytial Virus (RSV) Product Type and Technology

5.1.2.1 Ribavirin

5.1.2.2 Bronchodilator

5.1.3 Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)

5.2 ADMA Biologics

5.2.1 Company Basic Information,Manufacturing Base and Competitors

5.2.2 Pharmaceuticals Product Type and Technology

5.2.2.1 Ribavirin

5.2.2.2 Bronchodilator

5.2.3 Pharmaceuticals Sales, Revenue, Price of ADMA Biologics (2015 and 2016)

5.3 Agilvax

5.3.1 Company Basic Information,Manufacturing Base and Competitors

5.3.2 Agilvax Product Type and Technology

5.3.2.1 Ribavirin

5.3.2.2 Bronchodilator

5.3.3 Agilvax Sales, Revenue, Price of Agilvax (2015 and 2016)

5.4 AlphaVax

5.4.1 Company Basic Information,Manufacturing Base and Competitors

5.4.2 AstraZeneca Product Type and Technology

5.4.2.1 Ribavirin

5.4.2.2 Bronchodilator

5.4.3 AlphaVax Sales, Revenue, Price of AlphaVax (2015 and 2016)

5.5 AmVac

5.5.1 Company Basic Information,Manufacturing Base and Competitors

5.5.2 AmVac Product Type and Technology

5.5.2.1 Ribavirin

5.5.2.2 Bronchodilator

5.5.3 AmVac Sales, Revenue, Price of AmVac (2015 and 2016)

5.6 Aridis Pharmaceuticals

5.6.1 Company Basic Information,Manufacturing Base and Competitors

5.6.2 Aridis Pharmaceuticals Product Type and Technology

5.6.2.1 Ribavirin

5.6.2.2 Bronchodilator

5.6.3 Aridis Pharmaceuticals Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)

5.7 Artificial Cell Technologies

5.7.1 Company Basic Information,Manufacturing Base and Competitors

5.7.2 Artificial Cell Technologies Product Type and Technology

5.7.2.1 Ribavirin

5.7.2.2 Bronchodilator

5.7.3 Artificial Cell Technologies Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)

5.8 Astellas Pharma

5.8.1 Company Basic Information,Manufacturing Base and Competitors

5.8.2 Astellas Pharma Product Type and Technology

5.8.2.1 Ribavirin

5.8.2.2 Bronchodilator

5.8.3 Astellas Pharma Sales, Revenue, Price of Astellas Pharma (2015 and 2016)

5.9 AstraZeneca

5.9.1 Company Basic Information,Manufacturing Base and Competitors

5.9.2 AstraZeneca Product Type and Technology

5.9.2.1 Ribavirin

5.9.2.2 Bronchodilator

5.9.3 AstraZeneca Sales, Revenue, Price of AstraZeneca (2015 and 2016)

5.10 Bavarian Nordic

5.10.1 Company Basic Information,Manufacturing Base and Competitors

5.10.2 Bavarian Nordic Product Type and Technology

5.10.2.1 Ribavirin

5.10.2.2 Bronchodilator

5.10.3 Bavarian Nordic Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)

5.11 Biota Pharmaceuticals

5.12 Celltrion

5.13 Codagenix

5.14 Crucell

5.15 CureVac

5.16 Emergent

5.17 Roche

5.18 GenVec

5.19 Gilead Sciences

5.20 GlaxoSmithKline

5.21 Humabs BioMed

5.22 Novavax

6 Drugs for Respiratory Syncytial Virus (RSV) Technology and Development Trend

6.1 Drugs for Respiratory Syncytial Virus (RSV) Technology Analysis

6.2 Drugs for Respiratory Syncytial Virus (RSV) Technology Development Trend

7 Research Findings and Conclusion

List of Tables and Figures

Figure Picture of Drugs for Respiratory Syncytial Virus (RSV)

Table Classification of Drugs for Respiratory Syncytial Virus (RSV)

Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type in 2015

Figure Ribavirin Picture

Figure Bronchodilator Picture

Table Applications of Drugs for Respiratory Syncytial Virus (RSV)

Figure USA Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application in 2015

Figure Infants (Under 6 Month Old) Examples

Figure Babies & Children Examples

Figure Adults Examples

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue and Price (2011-2021)

Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Growth Rate (2011-2021)

Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Growth Rate (2011-2021)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales of Key Manufacturers (2015 and 2016)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers

Figure 2016 Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Manufacturers

Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue by Manufacturers (2015 and 2016)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers (2015 and 2016)

Table 2015 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers

Table 2016 USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Manufacturers

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Type (2011-2021)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Type (2011-2021)

Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)

Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Type (2011-2021)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue and Market Share by Type (2011-2021)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Share by Type (2011-2021)

Figure Revenue Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Type (2011-2021)

Figure USA Drugs for Respiratory Syncytial Virus (RSV) Revenue Growth Rate by Type (2011-2021)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales and Market Share by Application (2011-2021)

Table USA Drugs for Respiratory Syncytial Virus (RSV) Sales Share by Application (2011-2021)

Figure Sales Market Share of Drugs for Respiratory Syncytial Virus (RSV) by Application (2011-2021)

Figure USA Drugs for Respiratory Syncytial Virus (RSV) Sales Growth Rate by Application (2011-2021)

Table Ablynx Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Ablynx (2015 and 2016)

Table ADMA Biologics Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of ADMA Biologics (2015 and 2016)

Table Agilvax Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Agilvax (2015 and 2016)

Table AlphaVax Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AlphaVax (2015 and 2016)

Table AmVac Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AmVac (2015 and 2016)

Table Aridis Pharmaceuticals Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Aridis Pharmaceuticals (2015 and 2016)

Table Artificial Cell Technologies Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Artificial Cell Technologies (2015 and 2016)

Table Astellas Pharma Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Astellas Pharma (2015 and 2016)

Table AstraZeneca Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of AstraZeneca (2015 and 2016)

Table Bavarian Nordic Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Bavarian Nordic (2015 and 2016)

Table Biota Pharmaceuticals Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Biota Pharmaceuticals (2015 and 2016)

Table Celltrion Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Celltrion (2015 and 2016)

Table Codagenix Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Codagenix (2015 and 2016)

Table Crucell Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Crucell (2015 and 2016)

Table CureVac Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of CureVac (2015 and 2016)

Table Emergent Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Emergent (2015 and 2016)

Table Roche Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Roche (2015 and 2016)

Table GenVec Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GenVec (2015 and 2016)

Table Gilead Sciences Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Gilead Sciences (2015 and 2016)

Table GlaxoSmithKline Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of GlaxoSmithKline (2015 and 2016)

Table Humabs BioMed Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Humabs BioMed (2015 and 2016)

Table Novavax Basic Information List

Table Drugs for Respiratory Syncytial Virus (RSV) Sales, Revenue, Price of Novavax (2015 and 2016)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370